In this study, the authors compared acupoint embedding therapy and compared to polyene phosphatidylcholine capsules in the clinical efficacy on non-alcoholic fatty liver disease (NAFLD) based on the traditional Chinese medicine diagnosis of liver stagnation and spleen deficiency patterns ^[1]. This was a multi-center clinical trial with 180 cases of NAFLD. The therapy was BL18, LR3, ST40, ST36, SP6 once every 7 days and the capsules were taken twice three times daily. Ultrasound and blood tests were used as outcome measures. The results showed that the therapy achieved efficacy on NAFLD better than the capsules. Blood results improved (ALT, AST, TC, TG) and all results were significant.